title: Taking the profit out of biomedical research tools.
abstract: A National Institutes of Health proposal will restrict the licensing of Federally funded biomedical research tools for commercial gain.
authors.affiliation: Campbell & Flores LLP, 4370 La Jolla Village Drive, Suite 700, San Diego, CA 92122, USA. mflores@candf.com
authors.forename: M A
authors.initials: MA
authors.lastname: Flores
mesh_terms: D035843:Biomedical Research; D004345:Drug Industry; D035082:Federal Government; D005380:Financing, Government; D033161:Government Regulation; D017408:Guidelines as Topic; D007449:Investments; D009316:National Institutes of Health (U.S.); D010330:Patents as Topic / Q000331:legislation & jurisprudence; D017149:Private Sector; D012109:Research Support as Topic; D014481:United States